VIR
$9.48
Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
Recent News
Vir Biotechnology Astellas Deal Puts VIR-5500 And Valuation In Focus
Vir Biotechnology (NasdaqGS:VIR) announced a global collaboration with Astellas Pharma to develop and commercialize VIR-5500 for metastatic castration-resistant prostate cancer. The agreement includes substantial upfront and near-term funding to support VIR-5500 and broader pipeline development. Positive Phase 1 data for VIR-5500 reported promising anti-tumor activity and safety in prostate cancer patients. The deal marks Vir's entry into high-profile immuno-oncology partnerships and...
TheStreet Pro: Four Stocks that Will Win Despite “Irrational Panic” over AI
The big news this week is AI may not be the economic savior that companies were hoping for. Sure, AI will help cut costs and make companies more profitable. At least, initially. What happens next is the big question. On Monday, the stock market dropped after an investment shop called Citrini Research released a hypothetical scenario about how the economy could look in 2028. And it’s not pretty. Citrini’s “Global Intelligence Crisis” hypothesizes that AI could cause skyrocketing white-collar unem
Company News for Feb 25, 2026
Companies In The Article Are:HD,VIR,AMD,META and NRG
A Look At Vir Biotechnology (VIR) Valuation After Astellas Collaboration On VIR-5500 And Early Phase 1 Update
Vir Biotechnology (VIR) has drawn fresh investor attention after announcing a global collaboration with Astellas around VIR-5500, a dual-masked T-cell engager for metastatic castration-resistant prostate cancer, backed by encouraging early Phase 1 data. See our latest analysis for Vir Biotechnology. The recent collaboration news, strong VIR-5500 Phase 1 update and follow-on equity plans appear to have reset expectations. A 1-day share price return of 27.7% has helped lift the year-to-date...
These Stocks Are Today’s Movers: AMD, Hims & Hers, Keysight, IBM, Kratos, Vir Biotechnology, Whirlpool, and More
Advanced Micro Devices rallies after the chip maker unveils a multiyear deal to supply computing power to Meta Platforms.